We offer special thanks to Nancy Ostrove, recently retired from her position as Director, Risk Communication Staff, Office of Planning of the US Food and Drug Administration (FDA), and Lee Zwanziger, Designated Federal Official for FDA’s Risk Communication Advisory Committee. Without them, this guide, like so many of FDA’s initiatives, would not have happened. We also thank Nancy Derr and Elena Ketelhut for their thoughtful and patient help in seeing the guide through the production process. Finally, we thank the guide’s authors and reviewers. Each has either served on the Committee or supported its work. Each has also had a role in creating the field of risk communication, producing its research foundations or making communications work in ways that are …show more content…
53 Chapter 8: Qualitative Information - Julie Downs, Baruch Fischhoff ................................ 65 Chapter 9: Health Literacy - Michael Wolf........................................................................ 77 Chapter 10: Affect and Emotion - Ellen Peters.................................................................. 89 Chapter 11: Information and Persuasion - Mary Brown, Christine Bruhn ...................... 101 Chapter 12: Across the Life Span - Valerie Reyna ........................................................... 111 Chapter 13: Health Care Professionals - Betsy Sleath, Michael Goldstein ...................... 121 Communication Design Chapter 14: Readability, Comprehension, and Usability - Linda Neuhauser, Kala Paul.... 129 Chapter 15: Warnings and Disclosures - J. Craig Andrews.............................................. 149 Chapter 16: Human Factors - Gavin Huntley-Fenner ...................................................... 163 Chapter 17: Shared Decision Making - Nananda Col......................................................